相关实验视频

Updated: Jul 9, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

在FLT3突变的急性髓性白血病中CPX-351

Claire Andrews¹, Vinod Pullarkat², Christian Recher³

¹Department of Haematology, St Vincent's University Hospital, Dublin, Ireland.

Frontiers in oncology

|December 4, 2023

概括

脂质体化疗CPX-351为新诊断的高风险急性髓性白血病 (AML) 提供了更好的生存期. 有证据表明,在结合FLT3抑制剂时,对FLT3突变AML患者有潜在的益处.

科学领域:

血液学血液学血液学
在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

CPX-351是一种脂质体封装的诺鲁宾和cytarabine.
它被批准用于新诊断的与治疗相关的AML或AML与骨髓质形成相关的变化.
在新诊断的AML患者中,FLT3突变存在于约30%的患者中,并且与较差的结局有关.

研究的目的:

审查CPX-351在具有FLT3突变的AML患者中使用的证据.
探索将CPX-351与FLT3抑制剂结合的潜力.

主要方法:

审查体外,临床和现实世界的证据.
从临床试验和病例报告中分析初步数据.

主要成果:

与标准7+3化疗相比,CPX-351在高风险/二次AML的III期试验中显著改善了整体存活率.
初步数据表明,与FLT3抑制剂结合的CPX-351可能是FLT3突变AML的可行的治疗选择.

结论:

CPX-351是针对特定AML亚型的有效治疗方法.
结合FLT3抑制剂的联合治疗对FLT3突变AML有希望.

关键词:

在CPX-351中使用.FLT3 抑制剂的使用.在FLT3突变中.急性骨髓性白血病 (AML) 是一种急性骨髓性白血病.化学疗法化疗化疗

更多相关视频

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...